Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin vs Heparin for VTE Prevention in Gynecologic Oncology
NCT01356329Phase 3Suspended
- Sponsor
- Ministry of National Guard Health Affairs
- Start
- Oct 2009
- Primary completion
- Aug 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of enoxaparin in venous thromboembolism (VTE), sponsored by Ministry of National Guard Health Affairs. Started Oct 2009; status: suspended.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT01356329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01356329.